基于纳米技术提高氯喹和羟氯喹疗效的方法--综述

Vitória Maryana da Silva Borrero, Luiza Regina Voigt, Luciana Oliveira de Fariña, Isabela Angeli de Lima
{"title":"基于纳米技术提高氯喹和羟氯喹疗效的方法--综述","authors":"Vitória Maryana da Silva Borrero, Luiza Regina Voigt, Luciana Oliveira de Fariña, Isabela Angeli de Lima","doi":"10.9734/jammr/2024/v36i35382","DOIUrl":null,"url":null,"abstract":"Background: Chloroquine (CQ) and hydroxychloroquine (HCQ) are widely used in the treatment of endemic diseases such as malaria and autoimmune conditions like rheumatoid arthritis. Their anti-apoptotic activity, cost-effectiveness, and convenient oral administration make them effective treatments, either as standalone therapies or in combination with other drugs. However, their use is limited by a narrow therapeutic window, which can lead to potential complications due to organ accumulation and non-specific actions in healthy cells. This risk necessitates exploration into safer clinical applications using nanotechnology. \nAim: This scoping review aims to comprehensively assess and analyze the application of nanotechnology to enhance the therapeutic efficacy and safety of CQ and HCQ. \nMethods: A meticulous search for original studies on nanoparticle formulations of “chloroquine” and “hydroxychloroquine” was conducted. Two reviewers screened titles and abstracts, followed by a detailed assessment of the full articles. Inclusion criteria encompassed original studies in English, Spanish, or Portuguese, focusing on in vitro, in vivo, and ex vivo evaluations. \nResults: After an exhaustive search across selected databases, 30 articles were meticulously chosen for comprehensive evaluation. The most common properties found for nanoparticles included sizes ranging from 100 to 300 nm, a zeta potential lower than -10, with dendritic derivatives being the most encountered types. Materials used in both production and coating varied, influencing the release and specificity of the nanocarrier. Among therapeutic activities, antimalarial and antitumor activities were the most studied. \nConclusion: Studies have demonstrated distinct characteristics acquired by these drugs after encapsulation in various nanoparticles, including reduced toxicity, increased specificity, prolonged systemic circulation, absence of toxic peaks, and potential for different therapeutic approaches.","PeriodicalId":14869,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"42 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nanotechnology Based Approaches to Enhance Therapeutic Efficacy of Chloroquine and Hydroxychloroquine– A Review\",\"authors\":\"Vitória Maryana da Silva Borrero, Luiza Regina Voigt, Luciana Oliveira de Fariña, Isabela Angeli de Lima\",\"doi\":\"10.9734/jammr/2024/v36i35382\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Chloroquine (CQ) and hydroxychloroquine (HCQ) are widely used in the treatment of endemic diseases such as malaria and autoimmune conditions like rheumatoid arthritis. Their anti-apoptotic activity, cost-effectiveness, and convenient oral administration make them effective treatments, either as standalone therapies or in combination with other drugs. However, their use is limited by a narrow therapeutic window, which can lead to potential complications due to organ accumulation and non-specific actions in healthy cells. This risk necessitates exploration into safer clinical applications using nanotechnology. \\nAim: This scoping review aims to comprehensively assess and analyze the application of nanotechnology to enhance the therapeutic efficacy and safety of CQ and HCQ. \\nMethods: A meticulous search for original studies on nanoparticle formulations of “chloroquine” and “hydroxychloroquine” was conducted. Two reviewers screened titles and abstracts, followed by a detailed assessment of the full articles. Inclusion criteria encompassed original studies in English, Spanish, or Portuguese, focusing on in vitro, in vivo, and ex vivo evaluations. \\nResults: After an exhaustive search across selected databases, 30 articles were meticulously chosen for comprehensive evaluation. The most common properties found for nanoparticles included sizes ranging from 100 to 300 nm, a zeta potential lower than -10, with dendritic derivatives being the most encountered types. Materials used in both production and coating varied, influencing the release and specificity of the nanocarrier. Among therapeutic activities, antimalarial and antitumor activities were the most studied. \\nConclusion: Studies have demonstrated distinct characteristics acquired by these drugs after encapsulation in various nanoparticles, including reduced toxicity, increased specificity, prolonged systemic circulation, absence of toxic peaks, and potential for different therapeutic approaches.\",\"PeriodicalId\":14869,\"journal\":{\"name\":\"Journal of Advances in Medicine and Medical Research\",\"volume\":\"42 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Advances in Medicine and Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/jammr/2024/v36i35382\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Medicine and Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jammr/2024/v36i35382","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:氯喹(CQ)和羟氯喹(HCQ)被广泛用于治疗疟疾等地方病和类风湿性关节炎等自身免疫性疾病。这两种药物具有抗细胞凋亡活性、成本效益高、口服方便等特点,因此无论是作为独立疗法还是与其他药物联合使用,都是有效的治疗方法。然而,它们的使用受到治疗窗口狭窄的限制,可能会因器官蓄积和对健康细胞的非特异性作用而导致潜在的并发症。因此,有必要利用纳米技术探索更安全的临床应用。目的:本综述旨在全面评估和分析纳米技术在提高 CQ 和 HCQ 治疗效果和安全性方面的应用。方法:对有关 "氯喹 "和 "羟氯喹 "纳米颗粒制剂的原始研究进行了细致的检索。两名审稿人筛选了标题和摘要,然后对文章全文进行了详细评估。纳入标准包括英文、西班牙文或葡萄牙文的原创研究,重点是体外、体内和体外评估。结果:在对选定的数据库进行详尽搜索后,我们精心挑选了 30 篇文章进行全面评估。所发现的纳米粒子最常见的特性包括:大小从 100 纳米到 300 纳米不等,zeta 电位低于-10,树枝状衍生物是最常见的类型。生产和涂层所用的材料各不相同,影响着纳米载体的释放和特异性。在治疗活性方面,研究最多的是抗疟和抗肿瘤活性。结论研究表明,这些药物封装在不同的纳米颗粒中后具有不同的特性,包括毒性降低、特异性增强、全身循环时间延长、无毒性峰值以及不同治疗方法的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Nanotechnology Based Approaches to Enhance Therapeutic Efficacy of Chloroquine and Hydroxychloroquine– A Review
Background: Chloroquine (CQ) and hydroxychloroquine (HCQ) are widely used in the treatment of endemic diseases such as malaria and autoimmune conditions like rheumatoid arthritis. Their anti-apoptotic activity, cost-effectiveness, and convenient oral administration make them effective treatments, either as standalone therapies or in combination with other drugs. However, their use is limited by a narrow therapeutic window, which can lead to potential complications due to organ accumulation and non-specific actions in healthy cells. This risk necessitates exploration into safer clinical applications using nanotechnology. Aim: This scoping review aims to comprehensively assess and analyze the application of nanotechnology to enhance the therapeutic efficacy and safety of CQ and HCQ. Methods: A meticulous search for original studies on nanoparticle formulations of “chloroquine” and “hydroxychloroquine” was conducted. Two reviewers screened titles and abstracts, followed by a detailed assessment of the full articles. Inclusion criteria encompassed original studies in English, Spanish, or Portuguese, focusing on in vitro, in vivo, and ex vivo evaluations. Results: After an exhaustive search across selected databases, 30 articles were meticulously chosen for comprehensive evaluation. The most common properties found for nanoparticles included sizes ranging from 100 to 300 nm, a zeta potential lower than -10, with dendritic derivatives being the most encountered types. Materials used in both production and coating varied, influencing the release and specificity of the nanocarrier. Among therapeutic activities, antimalarial and antitumor activities were the most studied. Conclusion: Studies have demonstrated distinct characteristics acquired by these drugs after encapsulation in various nanoparticles, including reduced toxicity, increased specificity, prolonged systemic circulation, absence of toxic peaks, and potential for different therapeutic approaches.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信